尾状核为主的多巴胺能缺陷可区分伴帕金森综合征的行为变异型额颞叶痴呆
本研究纳入30例伴帕金森综合征的行为变异型额颞叶痴呆(bvFTD-P)患者,行多巴胺转运体(DAT)PET显像,并与进行性核上性麻痹(PSP)、多系统萎缩-帕金森型(MSA-P)、帕金森病(PD)及健康对照比较,发现bvFTD-P呈尾状核为主的多巴胺能缺陷模式,尾状核/后壳核(C/PP)比值鉴别诊断效能优于绝对摄取值。
要点
- bvFTD-P患者DAT PET显示尾状核、前壳核和后壳核摄取均显著低于健康对照(均P<0.01)。
- bvFTD-P呈尾状核为主缺陷模式(C/AP和C/PP比值降低),区别于PSP、MSA-P和PD的壳核为主模式。
- C/PP比值鉴别bvFTD-P与健康对照或其他帕金森综合征的效能优于绝对摄取值。
核心结论
- bvFTD-P的尾状核为主纹状体多巴胺能缺陷模式可作为与PSP、MSA-P和PD鉴别的影像生物标志物。
研究设计与样本
- 回顾性比较研究,纳入30例bvFTD-P患者行11C-CFT或18F-FP-CIT PET,并与71例PSP、41例MSA-P、61例PD和43例健康对照比较。
主要发现
- bvFTD-P患者尾状核、前壳核和后壳核DAT摄取较健康对照显著降低(均P<0.01)。
- bvFTD-P呈尾状核为主缺陷模式(C/AP和C/PP比值降低),而PSP、MSA-P和PD呈壳核为主丢失。
- 该尾状核为主模式在独立18F-FP-CIT队列中重复验证。
- ROC分析显示C/PP比值鉴别bvFTD-P与健康对照或其他帕金森综合征的效能优于绝对摄取值。
- 纹状体DAT降低的偏侧性与主要运动症状侧别相对应。
关键数值与推荐
- bvFTD-P患者尾状核、前壳核和后壳核DAT摄取均显著低于健康对照(均P<0.01)。
临床怎么用
- 对伴帕金森综合征的bvFTD患者行DAT PET显像,关注尾状核为主缺陷模式及C/PP比值以辅助鉴别诊断。
- C/PP比值较绝对摄取值更具鉴别诊断优势,可用于区分bvFTD-P与PSP、MSA-P和PD。
局限性
- 未报告患者的临床特征、扫描时间、随访信息及多中心外部验证等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Behavioral variant of frontotemporal dementia (bvFTD) often presents with parkinsonism. Our study aimed to characterize the dopaminergic deficit pattern in bvFTD-parkinsonism (bvFTD-P) using dopamine transporter (DAT) positron emission tomography (PET) and to assess its potential value in differentiating bvFTD-P from progressive supranuclear palsy (PSP), multiple system atrophy-parkinsonism (MSA-P), and Parkinson disease (PD). METHODS: A total of 30 bvFTD-P patients underwent 11 C-CFT or 18 F-FP-CIT PET and were compared with 71 patients with PSP, 41 with MSA-P, 61 with PD, and 43 healthy controls (HC). DAT binding values in the caudate, anterior putamen, and posterior putamen, as well as caudate/anterior putamen (C/AP) and caudate/posterior putamen (C/PP) ratios, were analyzed with generalized linear models. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic accuracy of DAT binding values and ratios. RESULTS: BvFTD-P patients exhibited significantly reduced DAT binding in the caudate, anterior putamen, and posterior putamen compared with HC (all P <0.01), with a caudate-predominant deficit pattern (lower C/AP and C/PP ratios), contrasting with the putamen-predominant loss observed in PSP, MSA-P, and PD. This caudate-predominant pattern was replicated in the independent 18 F-FP-CIT cohort. ROC analysis demonstrated that the C/PP ratio provided superior discriminatory performance between bvFTD-P and HC or other parkinsonian syndromes than absolute binding values. Furthermore, lateralization of striatal DAT reduction corresponded to the side of predominant motor symptoms. CONCLUSIONS: The caudate-predominant pattern of striatal dopaminergic deficit in bvFTD-P may serve as a useful imaging biomarker for differentiating it from PSP, MSA-P, and PD.
引用
- Feng L, Liu W, Zhao YX, et al. Caudate-Predominant Striatal Dopaminergic Deficit Distinguishes Behavioral Variant of Frontotemporal Dementia With Parkinsonism From Other Parkinsonian Syndromes. Clin Nucl Med. 2026. PMID: 42474399. doi:10.1097/RLU.0000000000006597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。